Affiliation:
1. Newfoundland and Labrador Health Services, Memorial University of Newfoundland, St John's Newfoundland and Labrador, Canada
2. Memorial University of Newfoundland, St John's Newfoundland and Labrador, Canada
3. Correspondence: Cindy Whitten, Newfoundland and Labrador Health Services, St John's Newfoundland and Labrador, A1B 3V6 Canada.
Abstract
Background: Global elimination of hepatitis C virus (HCV) is feasible using existent tools. Reporting the provincial HCV care cascade will contribute to national and global HCV elimination efforts. Methods: This observational study was a secondary use of population-level medical record data, including laboratory results for HCV testing and prescription data for HCV treatment in the province of Newfoundland and Labrador (NL). All patients with HCV antibody testing performed between Jan 1, 2017 and Jan 1, 2022 were included. All prescriptions dispensed from a community pharmacy in NL for any HCV treatment during the same period were included. Results: There were 84,252 antibody tests included. Of these, 3,626 (4.3%) tests were positive for HCV antibodies. Seventy eight percent (1,377/1,766) of the individuals with positive antibody tests were tested for HCV RNA. Only 377/1,061 (35.5%) individuals with a positive RNA test were treated, and 257/395 (65.1%) achieved sustained virological response at 12 weeks. Conclusions: NL has successfully identified and treated HCV, but treatment access is low. Targets for improvement include increased screening, reflex testing of positive antibody with RNA, increased linkage to care, change in treatment funding policy, and quicker treatment funding decision.
Publisher
University of Toronto Press Inc. (UTPress)
Reference14 articles.
1. Public Health Agency of Canada. Reducing the health impact of sexually transmitted and blood-borne infections in Canada by 2030: a Pan-Canadian STBBI Framework for Action; 2018. https://www.canada.ca/content/dam/phac-aspc/documents/services/infectious-diseases/sexual-health-sexually-transmitted-infections/reports-publications/sexually-transmitted-blood-borne-infections-action-framework/sexually-transmitted-blood-borne-infections-action-framework.pdf (accessed November 2022).
2. Action Hepatitis Canada. Progress towards viral hepatitis elimination by 2030 in Canada; 2021. https://www.actionhepatitiscanada.ca/progressreport (accessed November 2022).
3. The Canadian Network on Hepatitis C Blueprint Writing Committee and Working Groups. Blueprint to inform hepatitis C elimination efforts in Canada; 2019. https://www.canhepc.ca/sites/default/files/media/documents/blueprint_hcv_2019_05.pdf (accessed November 2022).
4. Office of Infectious Disease and HIV/AIDS Policy (OIDP). Hepatitis C basics; 2022. https://www.hhs.gov/hepatitis/learn-about-viral-hepatitis/hepatitis-c-basics/index.html (accessed September, 2023).